Before You Think About Selling, Fix the Story Your Numbers Are Telling

Most practice owners think about selling in terms of valuation multiples.

What’s my EBITDA?
What multiple can I get?
What are comparable practices selling for?

Those are the right questions, but they’re incomplete.

Because buyers not only evaluate your revenue and your profit, they evaluate how much they can trust those numbers.

Two practices can show the same EBITDA on paper and receive very different valuations.

The difference is rarely the math. It’s the confidence behind it. And in most medical practices, that confidence is shaped by one thing more than anything else:

Your revenue cycle management.

Buyers Want Durability.

When a buyer evaluates a medical practice, they’re not just looking at historical performance. They’re asking a forward-looking question:

Will this cash flow hold up after the transition?

That question drives everything—from valuation to deal structure to how much cash you receive at closing.

If there’s uncertainty, it shows up in predictable ways:

• Lower valuation multiples

• Earnouts tied to future performance

• Holdbacks and working capital adjustments

• Increased diligence scrutiny

None of those are inherently bad. But they are signals.

They reflect a gap between reported performance and perceived reliability.

Where That Doubt Comes From

In many cases, the concern isn’t clinical. It’s operational.

More specifically, it sits inside the medical billing and revenue cycle process.

From the outside, a practice may look strong:

• Growing revenue

• Healthy EBITDA margins

• Consistent patient volume

But when buyers dig deeper, they’re looking for stability beneath those numbers.

And this is where issues tend to surface.

1. EBITDA Quality

Not all EBITDA is created equal.

Buyers are trying to determine how much of your earnings are:

• Repeatable

• Predictable

• Free from correction or cleanup

If your revenue cycle management relies heavily on manual intervention like chasing denials, correcting claims, and reworking accounts, that raises a question:

How much of this profit depends on effort that may not scale or transfer?

A few indicators that create concern:

• High denial rates or inconsistent trends

• Large adjustments or write-offs late in the revenue cycle

• Revenue spikes tied to cleanup efforts rather than steady performance

These don’t necessarily reduce profit today, but they introduce uncertainty about tomorrow.

2. Sustainability of Cash Flow

Revenue is one thing. Cash flow is another.

Buyers focus heavily on:

• Days in A/R

• Net collection rate

• First-pass resolution rate

Because these metrics tell a story about how efficiently your practice converts visits into cash. Strong benchmarks typically look like:

• Net collection rate above 95%

• Denial rates below 5%

• First-pass resolution rates in the 70–85% range

When performance drifts outside of these ranges, it signals potential leakage. More importantly, it raises a question:

Is this cash flow dependent on constant intervention?

If the answer is yes, buyers tend to discount it.

3. Handoff Risk

Every transaction includes a transition period. The buyer is stepping into your systems, your team, and your workflows. If your medical billing and RCM processes are not clearly defined and repeatable, that transition becomes riskier.

Common concerns include:

• Key-person dependency within the billing team

• Inconsistent processes across locations

• Limited documentation of workflows

• Reliance on tribal knowledge rather than structured systems

From a buyer’s perspective, this creates execution risk. They’re not only acquiring a business, they’re inheriting its complexity.

The harder your revenue cycle is to understand, the harder it is to value with confidence.

How Revenue Cycle Impacts Valuation Readiness

Most owners think of valuation readiness in terms of financial statements. But increasingly, sophisticated buyers are looking beyond the P&L. They’re evaluating the infrastructure behind the numbers.

That includes:

• Consistency of medical billing processes

• Visibility into revenue cycle performance

• Stability of collections over time

• Clarity of roles and accountability

When those elements are strong, the financial story becomes easier to believe.

And when the story is believable, valuation tends to follow.

A Practical Self-Audit Before You Sell

Before entering a sale process, it’s worth stepping back and evaluating your revenue cycle through a buyer’s lens.

People

• Are roles within your billing and RCM team clearly defined?

• Is performance dependent on specific individuals?

Process

• Are workflows standardized across your practice?

• Can you clearly explain how a claim moves from intake to payment?

Reporting

• Do you have consistent visibility into key metrics like denial rate, A/R days, and collections?

• Are trends stable over time?

Accountability

• Is ownership of revenue cycle performance clearly assigned?

• Are issues resolved quickly and consistently?

You don’t need to be perfect, but you do need consistency, clarity, and control.

Reframing the Exit Conversation

Selling a medical practice is often framed as a financial event. In reality, it’s also an operational one.

Buyers are trying to answer this main question: Can this business perform the same way without the current owner?

Your revenue cycle plays a central role in that answer. It connects your clinical activity to your financial outcomes and it signals whether those outcomes are durable.

Closing Thought

A strong practice produces good numbers and numbers that are easy to trust.

Before you think about valuation multiples or deal structure, it’s worth considering the story your numbers are telling and how confident a buyer would be in that story.

Ultimately, valuation is not just about performance. It’s about confidence in what that performance represents.